Creepy, Invasive, and Exploitative Algorithms: A CPM Analysis of Users' Privacy Breakdowns and Recalibration Practices with Social Media Algorithms
Human-Machine Communication · 2025
DOI: 10.30658/hmc.10.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human-Machine Communication, 2025. Verfasst von Matthew Craig und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Social media content filtering algorithms can both provide desired personalized content and ads for users. However, sometimes these recommendations can resemble individual private information. How might users navigate these experiences to best manage their private information? The present exploratory study utilizes the rules- and systems-based framework of communication privacy management (CPM) theory to explore social media users’ experiences of privacy breakdowns with social media algorithms and investigates what users do in response to said breakdowns. These responses were refined using content analysis and divided into different categories of privacy breakdowns and recalibration strategies. Implications for future research surrounding human-machine communication privacy management are discussed in light of our findings.
Zitieren
APA
Craig, M., & Child, J. (2025). Creepy, Invasive, and Exploitative Algorithms: A CPM Analysis of Users' Privacy Breakdowns and Recalibration Practices with Social Media Algorithms. Human-Machine Communication. https://doi.org/10.30658/hmc.10.10
Vancouver
Craig M, Child J. Creepy, Invasive, and Exploitative Algorithms: A CPM Analysis of Users' Privacy Breakdowns and Recalibration Practices with Social Media Algorithms. Human-Machine Communication. 2025. doi:10.30658/hmc.10.10
BibTeX
@article{Craig2025,
author = {Craig, Matthew and Child, Jeffrey},
title = {Creepy, Invasive, and Exploitative Algorithms: A CPM Analysis of Users' Privacy Breakdowns and Recalibration Practices with Social Media Algorithms},
journal = {Human-Machine Communication},
year = {2025},
doi = {10.30658/hmc.10.10}
}
EUVIMED